250 related articles for article (PubMed ID: 22156972)
1. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
3. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
[TBL] [Abstract][Full Text] [Related]
4. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
[TBL] [Abstract][Full Text] [Related]
5. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
7. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
10. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China.
Chen X; Liu X; Tang R; Ye R; Yang Y; Yao S; Wang J; Ding Y; Duan S; He N
Biosci Trends; 2019 Mar; 13(1):32-39. PubMed ID: 30726798
[TBL] [Abstract][Full Text] [Related]
12. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
Kuniholm MH; Gao X; Xue X; Kovacs A; Marti D; Thio CL; Peters MG; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Young MA; Strickler HD; Carrington M
J Infect Dis; 2011 Jun; 203(12):1807-14. PubMed ID: 21606539
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
Nunes D; Fleming C; Offner G; Craven D; Fix O; Heeren T; Koziel MJ; Graham C; Tumilty S; Skolnik P; Stuver S; Horsburgh CR; Cotton D
Am J Gastroenterol; 2010 Jun; 105(6):1346-53. PubMed ID: 20179698
[TBL] [Abstract][Full Text] [Related]
14. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
[TBL] [Abstract][Full Text] [Related]
16. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
[TBL] [Abstract][Full Text] [Related]
17. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
[TBL] [Abstract][Full Text] [Related]
18. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
Moodie EE; Pant Pai N; Klein MB
PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
[TBL] [Abstract][Full Text] [Related]
19. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
20. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
